NEW YORK (360Dx) – Roche today said that the US Food and Drug Administration has approved the firm's fourth-generation HIV combination antigen-antibody assay for marketing.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.